SCHEMBL7374197

SCHEMBL7374197

N#Cc1cccc(Cn2ccc(CO)n2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.51
CYP11B1 P15538 1/20 0.51
CYP11B2 P19099 1/20 0.51
ALDH1A1 P00352 2/20 0.47
NOTUM Q6P988 1/20 0.46
CREBBP Q92793 1/20 0.43
HDAC1 Q13547 2/20 0.41
HDAC7 Q8WUI4 1/20 0.41
ROCK2 O75116 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
DRD2 P14416 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7375052 0.87 CYP19A1 (0.50) CYP19A1CYP11B1CYP11B2ALDH1A1CREBBP
SCHEMBL11553968 0.82 CYP19A1 (0.54) CYP19A1CYP11B1CYP11B2NOTUM
SCHEMBL1065891 0.81 ALDH1A1 (0.62) CYP19A1CYP11B1CYP11B2ALDH1A1CREBBP
SCHEMBL24991855 0.80 CYP19A1 (0.48) CYP19A1CYP11B1CYP11B2ALDH1A1CREBBP
SCHEMBL7375050 0.79 ADRA1D (0.48) CYP19A1CYP11B1CYP11B2ALDH1A1CREBBP
SCHEMBL7368765 0.78 CYP19A1 (0.46) CYP19A1CYP11B1CYP11B2ALDH1A1NOTUM
SCHEMBL5869934 0.76 HDAC1 (0.55) CYP19A1ALDH1A1HDAC1HDAC7HDAC3
SCHEMBL1068209 0.76 CYP19A1 (0.47) CYP19A1CYP11B1CYP11B2ALDH1A1CREBBP
SCHEMBL3920408 0.75 GRM5 (0.60) CYP19A1CYP11B1CYP11B2ALDH1A1
SCHEMBL25381660 0.75 ALDH1A1 (0.54) CYP19A1CYP11B1CYP11B2ALDH1A1CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002000651-A2 FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-01-03 WO disclosed